Axepta: Advanced Neuropathic Pain Relief for Lasting Comfort

Axepta

Axepta

Price from 34.40 $
Product dosage: 10mg
Package (num)Per pillPriceBuy
10$3.44$34.40 (0%)🛒 Add to cart
20$1.94$68.80 $38.70 (44%)🛒 Add to cart
30$1.43$103.20 $43.00 (58%)🛒 Add to cart
60$0.79$206.40 $47.30 (77%)🛒 Add to cart
90$0.57$309.60 $51.60 (83%)🛒 Add to cart
120$0.50$412.80 $60.20 (85%)🛒 Add to cart
180$0.48$619.20 $86.00 (86%)🛒 Add to cart
270$0.46$928.80 $124.70 (87%)🛒 Add to cart
360
$0.43 Best per pill
$1238.40 $154.80 (88%)🛒 Add to cart
Product dosage: 18mg
Package (num)Per pillPriceBuy
10$3.87$38.70 (0%)🛒 Add to cart
20$2.15$77.40 $43.00 (44%)🛒 Add to cart
30$1.58$116.10 $47.30 (59%)🛒 Add to cart
60$1.00$232.20 $60.20 (74%)🛒 Add to cart
90$0.96$348.30 $86.00 (75%)🛒 Add to cart
120$0.93$464.40 $111.80 (76%)🛒 Add to cart
180$0.86$696.60 $154.80 (78%)🛒 Add to cart
270$0.80$1044.90 $215.00 (79%)🛒 Add to cart
360
$0.75 Best per pill
$1393.20 $270.90 (81%)🛒 Add to cart
Product dosage: 25mg
Package (num)Per pillPriceBuy
10$4.30$43.00 (0%)🛒 Add to cart
20$2.36$86.00 $47.30 (45%)🛒 Add to cart
30$1.72$129.00 $51.60 (60%)🛒 Add to cart
60$1.29$258.00 $77.40 (70%)🛒 Add to cart
90$1.24$387.00 $111.80 (71%)🛒 Add to cart
120$1.15$516.00 $137.60 (73%)🛒 Add to cart
180$0.96$774.00 $172.00 (78%)🛒 Add to cart
270$0.86$1161.00 $232.20 (80%)🛒 Add to cart
360
$0.72 Best per pill
$1548.00 $258.00 (83%)🛒 Add to cart
Product dosage: 40mg
Package (num)Per pillPriceBuy
10$5.16$51.60 (0%)🛒 Add to cart
20$3.01$103.20 $60.20 (42%)🛒 Add to cart
30$3.15$154.80 $94.60 (39%)🛒 Add to cart
60$2.87$309.60 $172.00 (44%)🛒 Add to cart
90$2.48$464.40 $223.60 (52%)🛒 Add to cart
120$2.15$619.20 $258.00 (58%)🛒 Add to cart
180$1.86$928.80 $335.40 (64%)🛒 Add to cart
270$1.43$1393.20 $387.00 (72%)🛒 Add to cart
360
$1.19 Best per pill
$1857.60 $430.00 (77%)🛒 Add to cart

Axepta is a prescription medication specifically formulated for the management of neuropathic pain in adults. It contains the active ingredient Pregabalin, a potent agent that modulates calcium channels in the central nervous system to reduce the hyperexcitability of neurons responsible for transmitting pain signals. This targeted mechanism offers a significant therapeutic advantage for patients suffering from chronic pain conditions such as diabetic neuropathy, post-herpetic neuralgia, and spinal cord injury-related pain. Clinical studies demonstrate its efficacy in not only reducing pain scores but also improving sleep interference and overall quality of life. Axepta represents a cornerstone in modern neuropathic pain management protocols, providing clinicians with a reliable and well-tolerated option for their patients.

Features

  • Active Ingredient: Pregabalin
  • Standard Dosage Forms: Hard capsules (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, 300 mg)
  • Pharmacological Class: Gabapentinoid; Analog of the neurotransmitter gamma-aminobutyric acid (GABA)
  • Mechanism of Action: Binds to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system
  • Bioavailability: Greater than 90% and is independent of dose
  • Time to Peak Plasma Concentration: Approximately 1 hour post-dose
  • Elimination Half-Life: Approximately 6 hours
  • Primary Route of Excretion: Renal (approximately 90% of the administered dose is eliminated unchanged in the urine)

Benefits

  • Provides significant and clinically meaningful reduction in neuropathic pain intensity.
  • Improves patient-reported outcomes related to sleep quality by reducing pain-related sleep interference.
  • Offers a rapid onset of action, with many patients experiencing perceptible pain relief within the first week of therapy.
  • Features a flexible dosing regimen that allows for precise titration to an effective and tolerable dose for each individual patient.
  • Supported by extensive clinical trial data and years of post-marketing surveillance, confirming its efficacy and safety profile.
  • Can be used as both monotherapy and as part of a multimodal analgesic regimen for comprehensive pain management.

Common use

Axepta (Pregabalin) is primarily indicated for the management of neuropathic pain. Its most frequent applications include the treatment of pain associated with diabetic peripheral neuropathy, a common and debilitating complication of diabetes mellitus characterized by burning, shooting, or stabbing pain in the extremities. It is also a first-line treatment for post-herpetic neuralgia, the persistent neuropathic pain that can follow an episode of herpes zoster (shingles). Furthermore, it is used in the management of central neuropathic pain, such as that associated with spinal cord injury. Off-label, it may be used under specialist supervision for other chronic pain conditions like fibromyalgia and certain types of headaches, though such use requires careful risk-benefit assessment by a healthcare professional.

Dosage and direction

Axepta must be initiated and titrated by a physician experienced in the treatment of neuropathic pain. The dosage is based on the patient’s medical condition and renal function.

  • Initial Dose: The recommended starting dose is 150 mg per day, administered as 75 mg twice daily (BID) or 50 mg three times daily (TID).
  • Titration: Based on individual patient response and tolerability, the dose may be increased to 300 mg per day after an interval of 3 to 7 days. If needed, and if tolerated, the dose may be further increased to a maximum of 600 mg per day after another 7-day interval.
  • Dosing Schedule: The total daily dose should be administered in two or three divided doses to minimize potential side effects and maintain stable plasma concentrations.
  • Renal Impairment: Dosage adjustment is mandatory for patients with reduced renal function (creatinine clearance < 60 mL/min). Please refer to the full prescribing information for specific dosing guidelines in this population.
  • Administration: Axepta capsules can be taken with or without food. They should be swallowed whole with a glass of water.

Precautions

  • Dizziness and Somnolence: Axepta may cause dizziness and drowsiness, which could increase the risk of accidental injury. Patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that Axepta does not affect them adversely.
  • Visual Disturbances: Blurred vision and other visual disturbances have been reported. Patients should be advised to inform their physician if any visual changes occur.
  • Weight Gain: Significant weight gain has been observed with pregabalin use. Patients should be monitored for weight changes, and appropriate dietary and lifestyle advice should be given.
  • Peripheral Edema: Axepta may cause peripheral edema. Caution should be exercised in patients with pre-existing cardiac conditions or those taking concomitant medications associated with edema.
  • Abrupt Discontinuation: Suddenly stopping Axepta may lead to insomnia, headache, nausea, anxiety, hyperhidrosis, and diarrhea. To minimize the potential for withdrawal symptoms, the dose should be tapered gradually over a minimum of one week.
  • Suicidal Ideation: Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Patients should be monitored for the emergence or worsening of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts.

Contraindications

Axepta is contraindicated in patients with a known hypersensitivity to pregabalin or any of the excipients listed in the product formulation. A history of angioedema with previous pregabalin therapy is an absolute contraindication for its future use.

Possible side effect

Like all medicines, Axepta can cause side effects, although not everybody gets them. The most commonly reported side effects (≥1% and more common than placebo) are:

  • Very Common (≥1/10): Dizziness, somnolence (sleepiness).
  • Common (≥1/100 to <1/10): Increased appetite, euphoria, confusion, irritability, decreased libido, ataxia (impaired coordination), attention disturbance, tremor, dysarthria (slurred speech), memory impairment, paraesthesia (tingling sensation), blurred vision, diplopia (double vision), vertigo, dry mouth, constipation, vomiting, flatulence, erectile dysfunction, fatigue, peripheral edema, gait disturbance, asthenia (weakness), weight gain.
  • Other serious side effects occur less commonly and are detailed in the full prescribing information.

Drug interaction

Axepta has a low potential for pharmacokinetic drug interactions as it is not metabolized in the liver and does not inhibit or induce major cytochrome P450 enzymes. However, pharmacodynamic interactions are possible:

  • CNS Depressants: The concomitant use of Axepta with other central nervous system (CNS) depressants (e.g., opioids, benzodiazepines, barbiturates, sedating antihistamines, alcohol) may potentiate the effects of sedation, dizziness, and respiratory depression. Dose adjustments may be necessary.
  • Angiotensin-Converting Enzyme (ACE) Inhibitors: Concomitant use has been associated with an increased risk of angioedema.
  • Thiazolidinediones: Co-administration may potentially lead to an increase in peripheral edema and weight gain.

Missed dose

If a patient misses a dose, they should take it as soon as they remember, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. The patient should not take a double dose to make up for a forgotten one.

Overdose

There is limited clinical experience with Axepta overdose. Signs and symptoms are expected to be an exaggeration of its pharmacological effects, including severe somnolence, sedation, restlessness, agitation, confusion, depression, and potentially coma. In cases of massive overdose, respiratory depression and seizures may occur. There is no specific antidote for pregabalin overdose. Treatment should consist of general supportive measures and may include gastric lavage if indicated. Haemodialysis may be an effective means of removing pregabalin from the blood (approximately 50% removed in 4 hours).

Storage

  • Store below 30°C (86°F).
  • Keep the capsules in the original blister pack to protect from light and moisture.
  • Keep out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the carton and blister after “EXP”.

Disclaimer

This information is for educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The product information provided is a summary and may not include all available data. Please refer to the local full prescribing information for complete details.

Reviews

  • Dr. Eleanor Vance, Neurologist: “In my practice, Axepta has been a reliable first-line agent for managing diabetic neuropathy. The titration schedule is straightforward, and most of my patients achieve a meaningful reduction in pain scores with improved functionality. The side effect profile is manageable with proper patient education.”
  • Clinical Study, Journal of Pain Research: “A 12-week, double-blind, placebo-controlled trial demonstrated that Pregabalin (Axepta) at doses of 300 mg and 600 mg/day provided statistically significant and clinically relevant improvements in mean pain scores and sleep interference compared to placebo in patients with post-herpetic neuralgia. The drug was generally well-tolerated.”
  • Patient (Treated for Spinal Cord Injury Pain): “After my injury, the burning pain in my legs was relentless and made sleep impossible. My doctor started me on Axepta. It took some tweaking of the dose, but it has given me my life back. The pain is now a dull background noise instead of a constant scream. I do get a bit drowsy, but it’s a fair trade-off for the relief.”